Mouse Anti-ASPSCR1 Recombinant Antibody (CBT3207) (V2LY-0625-LY2080)

Wang, S., Pozner, A., Neison, M., Jones, K., & Shen, P. (2021). The role of the ASPL-TFE3 fusion protein in Alveolar Soft Part Sarcoma. Microscopy and Microanalysis, 27(S1), 1114-1116.

Coyne, G. O. S., Naqash, A. R., Sankaran, H., & Chen, A. P. (2021). Advances in the management of alveolar soft part sarcoma. Current problems in cancer, 45(4), 100775.

Yoshimatsu, Y., Noguchi, R., Tsuchiya, R., Sei, A., Sugaya, J., Fukushima, S., ... & Kondo, T. (2020). Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma. Human Cell, 33(4), 1302-1310.

Whaley, R. D., & Thompson, L. D. (2020). Primary thyroid gland alveolar soft part sarcoma. Head and neck pathology, 14(3), 701-706.

Dumont, S. N., Orbach, D., Coulomb-L’herminé, A., & Robin, Y. M. (2020). Alveolar Soft Part Sarcoma. In Rare Sarcomas (pp. 91-112). Springer, Cham.

Principe, D. R., Mohindra, N. A., Munshi, H. G., & Kamath, S. D. (2019). Alveolar soft part sarcoma mimics prostate cancer metastasis. Oxford medical case reports, 2019(12), 507-509.

Soheilifar, M. H., Taheri, R. A., Emameh, R. Z., Moshtaghian, A., Kooshki, H., & Motie, M. R. (2018). Molecular landscape in alveolar soft part sarcoma: implications for molecular targeted therapy. Biomedicine & Pharmacotherapy, 103, 889-896.

Rhee, D. S., Dunkel, I. J., Shukla, N. N., Walsh, M. F., Gilheeney, S. W., Price, A. P., ... & Heaton, T. E. (2017). Alveolar soft part sarcoma of the bladder with ASPSCR1-TFE3 gene fusion as a secondary malignancy. Journal of Pediatric Surgery Case Reports, 27, 19-22.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols